Navigation Links
Inaccurate diagnoses of melanoma by smartphone apps could delay doctor visits, life-saving treatment
Date:1/16/2013

PITTSBURGH, Jan. 16, 2013 Smartphone applications that claim to evaluate a user's photographs of skin lesions for the likelihood of cancer instead returned highly variable and often inaccurate feedback, according to a study led by researchers at the University of Pittsburgh School of Medicine. The findings, published in JAMA Dermatology and available online today, suggest that relying on these "apps" instead of consulting with a physician may delay the diagnosis of melanoma and timely, life-saving treatment.

"Smartphone usage is rapidly increasing, and the applications available to consumers have moved beyond communication and entertainment to everything under the sun, including health care," said lead researcher Laura Ferris, M.D., Ph.D., assistant professor, Department of Dermatology, University of Pittsburgh School of Medicine. "These tools may help patients be more mindful about their health care and improve communication between themselves and their physicians, but it's important that users don't allow their 'apps' to take the place of medical advice and physician diagnosis."

In fact, the study found that three out of the four smartphone applications tested incorrectly diagnosed 30 percent or more melanomas as "unconcerning" based on their evaluation of user images.

The study, funded by the National Institutes of Health (NIH) and the University of Pittsburgh Clinical and Translational Science Institute, reviewed applications available in the two most popular smartphone platforms and found that such tools often are marketed to nonclinical users to help them decide, using a digital image for analysis, whether or not their skin lesions are potential melanomas or otherwise concerning, or if they likely are benign. Researchers uploaded 188 images of skin lesions to each of the four applications, which then analyzed the images in different ways, including automated algorithms and images reviewed by an anonymous board-certified dermatologist. The applications often are available for free or at a very low cost, and are not subject to any regulatory oversight or validation.

Only the application that utilized dermatologists for a personal review of user images, essentially functioning as a tool to facilitate teledermatology, provided a high degree of sensitivity in diagnosis - just one of the 53 melanomas was diagnosed as "benign" by the experts reading the images. This application also was the most expensive, costing users $5 per image evaluation. Although the tools included disclaimers stating they were providing information for educational purposes only, researchers noted the risk that patients might rely on the application's evaluation rather than seek the advice of a medical professional.

The likelihood of relying on the application's free or low-cost evaluation is particularly concerning for the uninsured or economically disadvantaged, especially because a substantial number of melanomas are first detected by patients, noted the study authors. "If they see a concerning lesion but the smartphone app incorrectly judges it to be benign, they may not follow up with a physician," said Dr. Ferris. "Technologies that decrease the mortality rate by improving self- and early-detection of melanomas would be a welcome addition to dermatology. But we have to make sure patients aren't being harmed by tools that deliver inaccurate results."


'/>"/>

Contact: Carrie Stevenson
BeckerC@upmc.edu
412-586-9778
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Websites Touting Designer Vagina Surgeries Often Inaccurate, Study Finds
2. All-they-can-eat diet for lab mice and rats may foster inaccurate test results
3. 2 new vitamin D blood tests are often highly inaccurate, researchers say
4. Electronic visits offer accurate diagnoses, may lead to overprescribing of antibiotics
5. UMass Amherst chemists develop nose-like sensor array to smell cancer diagnoses
6. Missed Diagnoses in ICU Often Have Deadly Results: Review
7. Johns Hopkins team finds ICU misdiagnoses may account for as many annual deaths as breast cancer
8. Dr. Davis Announces Some Diagnoses of ADHD May be Misinterpreted Visual Problems: Could Be Treated with Vision Therapy
9. Drug-resistant melanoma tumors shrink when therapy is interrupted
10. Indication of considerable added benefit of vemurafenib in advanced melanoma
11. New screening approach identified potential drug combos for difficult-to-treat melanomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), ... company,s second affiliate in Latin America . ... ... Colombia ... ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
Breaking Medicine Technology: